Arkuda Therapeutics Funding: $64M Raised, Series B (2022)
Arkuda Therapeutics is based in Watertown. It has raised $64M in total funding. Latest round: Series B.
Arkuda Therapeutics funding overview
Arkuda Therapeutics is based in Watertown. Arkuda Therapeutics has raised $64M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in February 2022. The round record for Arkuda Therapeutics runs through 2022; nothing later has been disclosed. Investors on record include Atlas Venture, Eli Lilly and Company, Pfizer Ventures, Cormorant Asset Management, Pivotal Life Sciences, Surveyor Capital. 6 distinct backers are named across the disclosed rounds.
Arkuda Therapeutics at a glance
Total raised
$64M
Latest round
Series B
Latest round date
February 2022
Headquarters
Watertown
Notable investors
Atlas Venture, Eli Lilly and Company, Pfizer Ventures, Cormorant Asset Management, Pivotal Life Sciences, Surveyor Capital
Frequently asked about Arkuda Therapeutics funding
How much has Arkuda Therapeutics raised?
Arkuda Therapeutics has raised $64M in total disclosed funding across the rounds on record.
Who has invested in Arkuda Therapeutics?
Atlas Venture, Eli Lilly and Company, Pfizer Ventures, Cormorant Asset Management, Pivotal Life Sciences, Surveyor Capital are named among the investors backing Arkuda Therapeutics.
What was the latest Arkuda Therapeutics funding round?
The most recent disclosed round is a Series B, announced in February 2022.
Where is Arkuda Therapeutics based?
Arkuda Therapeutics is based in Watertown.
When did Arkuda Therapeutics last raise?
The last disclosed Arkuda Therapeutics round closed in February 2022 at Series B.
Every Arkuda Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Watertown at a similar stage.
